{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T21:41:28Z","timestamp":1777066888016,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.rmed.2018.10.027","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T23:03:05Z","timestamp":1540508585000},"page":"89-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Asthma features in severe COPD: Identifying treatable traits"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5227-0112","authenticated-orcid":false,"given":"Sandhya","family":"Matthes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Barton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4717-6922","authenticated-orcid":false,"given":"Gabriela","family":"Leuschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Munker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidrun","family":"Villena-Hermoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Frankenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Probst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaus","family":"Kneidinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Milger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9151-4829","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Behr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Neurohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2018.10.027_bib1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. reportGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2017 Report. www.goldcopd.org."},{"key":"10.1016\/j.rmed.2018.10.027_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00146306","article-title":"Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial","author":"Siva","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2018.10.027_bib3","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201509-1869OC","article-title":"Blood eosinophils and exacerbations in chronic obstructive pulmonary disease: the copenhagen general population study","author":"Vedel-Krogh","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2018.10.027_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","article-title":"Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial","volume":"186","author":"Bafadhel","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2018.10.027_bib5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2018.10.027_bib6","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1183\/09031936.06.00072105","article-title":"Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment","volume":"27","author":"Leigh","year":"2006","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2018.10.027_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejim.2016.06.020","article-title":"Fifteen-year mortality of patients with asthma-COPD overlap syndrome","volume":"34","author":"Sorino","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.rmed.2018.10.027_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4168\/aair.2017.9.5.431","article-title":"Asthma-copd overlap shows favorable clinical outcomes compared to pure COPD in a Korean COPD cohort","volume":"9","author":"Park","year":"2017","journal-title":"Allergy. Asthma Immunol. Res."},{"issue":"6","key":"10.1016\/j.rmed.2018.10.027_bib9","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1183\/09031936.00162414","article-title":"Eosinophilic inflammation in COPD: prevalence and clinical characteristics","volume":"44","author":"Singh","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2018.10.027_bib10","unstructured":"report2018 GINA Report Global Strategy for Asthma Management and Prevention."},{"key":"10.1016\/j.rmed.2018.10.027_bib11","first-page":"1745","article-title":"Is a previous diagnosis of asthma a reliable criterion for asthma\u2013COPD overlap syndrome in a patient with COPD?","volume":"10","author":"Barrecheguren","year":"2015","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2018.10.027_bib12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2147\/COPD.S44552","article-title":"Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study","volume":"9","author":"Donohue","year":"2014","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2018.10.027_bib13","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.2147\/COPD.S115378","article-title":"Importance of fractional exhaled nitric oxide in the differentiation of asthma\u2013COPD overlap syndrome, asthma, and COPD","volume":"11","author":"Chen","year":"2016","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2018.10.027_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/thx.51.3.267","article-title":"Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils","volume":"51","author":"St\u0103nescu","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2018.10.027_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(17)30217-5","article-title":"Eosinophils in COPD: just another biomarker?","author":"Bafadhel","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2018.10.027_bib16","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMoa1708208","article-title":"Mepolizumab for eosinophilic chronic obstructive pulmonary disease","volume":"377","author":"Pavord","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2018.10.027_bib17","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S2213-2600(17)30432-0","article-title":"Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort","volume":"5","author":"Hastie","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2018.10.027_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/thoraxjnl-2014-205634","article-title":"External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma","volume":"70","author":"Wagener","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2018.10.027_bib19","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00068-2017","article-title":"Algorithm for identification of asthma\u2013COPD overlap: consensus between the Spanish COPD and asthma guidelines","volume":"49","author":"Miravitlles","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2018.10.027_bib20","article-title":"Diagnostic criteria for the asthma-COPD overlap (ACO) still room for improvement","volume":"1","author":"Nu\u00f1ez","year":"2017","journal-title":"Mini Rev. Int J Pul Res Sci."},{"key":"10.1016\/j.rmed.2018.10.027_bib21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1183\/13993003.00436-2016","article-title":"What is asthma\u2212COPD overlap syndrome? Towards a consensus definition from a round table discussion","volume":"48","author":"Sin","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2018.10.027_bib22","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.chest.2017.05.019","article-title":"New anti-eosinophil drugs for asthma and COPD","volume":"152","author":"Bel","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2018.10.027_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2018.04.020","article-title":"Biologics and chronic obstructive pulmonary disease","author":"Pavord","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2018.10.027_bib24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.chest.2016.09.035","article-title":"Omalizumab treatment response in a population with severe allergic asthma and overlapping COPD","volume":"151","author":"Maltby","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2018.10.027_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4046\/trd.2017.80.1.11","article-title":"Asthma-copd overlap syndrome: what we know and what we don't","volume":"80","author":"Sin","year":"2017","journal-title":"Tuberc. Respir. Dis."},{"key":"10.1016\/j.rmed.2018.10.027_bib26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.chest.2016.10.003","article-title":"Eosinophils in COPD exacerbations are associated with increased readmissions","volume":"151","author":"Couillard","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2018.10.027_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2466-13-11","article-title":"Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation","volume":"13","author":"Schleich","year":"2013","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.rmed.2018.10.027_bib28","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1378\/chest.10-0087","article-title":"Pulmonary hypertension in COPD: epidemiology, significance, and management","volume":"137","author":"Minai","year":"2010","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2018.10.027_bib29","first-page":"390","article-title":"Pulmonary hypertension in chronic obstructive pulmonary disease","volume":"81","author":"Weitzenblum","year":"2013","journal-title":"Pneumonol. Alergol. Pol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611118303433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611118303433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:45:49Z","timestamp":1760615149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611118303433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":29,"alternative-id":["S0954611118303433"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2018.10.027","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asthma features in severe COPD: Identifying treatable traits","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2018.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}